Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Furnish price data:...

    Furnish price data: NPPA tells Knee implant manufactures, importers

    Written by Ruby Khatun Khatun Published On 2018-07-23T18:09:35+05:30  |  Updated On 23 July 2018 6:09 PM IST
    Furnish price data: NPPA tells Knee implant manufactures, importers

    New Delhi: Through a recent notification, National Pharmaceutical Pricing Authority (NPPA), Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India has directed manufacturers and importers of primary and revision knee implants to furnish price data to the authority.


    NPPA has requested the companies to furnish the data as per the format provided by NPPA in both hard and soft copies and send to NPPA latest by 30th July 2018. The soft copy of the data to be emailed to medicaldevices-nppa@gov.in.


    The authority has directed 15 companies to furnish the data including Meril Life Sciences.


    In Aug 2017, Medical Dialogues had reported that National Pharmaceuticals Pricing had fixed the ceiling prices of orthopaedic knee implants for knee replacement system and capped the prices of knee implants at a significantly lower rate than current market rates.


    The NPPA had fixed the price for primary knee replacement of titanium alloy at Rs 38,740 while the price for revision knee replacement of any material was pegged at Rs 62,770. The price of price for Hi-Flex primary knee replacement has been fixed at Rs 25,860 and that of cobalt chromium alloy at Rs 24,090.


    The prices for other primary knee replacement surgeries of femoral component, such as oxidised zirconium, had been fixed at Rs 38,740 by the pharma sector price regulator.


    The prices capped for primary knee replacement for tibial component or tibial tray made of titanium alloy and oxidised zirconium had been fixed at Rs 24,280.


    Read also: Knee Surgery Implants now under Price Ceiling, Effective Immediately


    Below is the attachment for the same

    askDepartment of PharmaceuticalsfurnishGovernment of Indiaimportersknee implantsknee replacement systemknee systemmanufacturersMinistry of Chemicals and FertilizersNational Pharmaceutical Pricing AuthorityNPPAorthopaedic knee implantsprice dataprimaryRevision

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok